drugset / Trial / NCT00940251

Evaluation of Safety and Efficacy of Mersina, an Ayurvedic Formulation: A Double Blind, Placebo Controlled Study in Type 2 Diabetic Patients With Secondary Failure to Oral Drugs

NCT00940251 ↗

Phase 2 Completed 26 enrolled Jyoti Clinical and Pathological Laboratory
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine the safety and efficacy of an Ayurvedic formulation, Mersina in type 2 diabetic patients with secondary failure to oral hypoglycemic agents, a randomized double blind, single centre, study of 3 months duration was carried out.

Timeline

Start
2008-09
Primary completion
2008-10
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mersina Traditional medicine (herbal / TCM) 3 g —

Indications

No indication recorded.